Isaac Neuhaus

Guest Editor for the following articles:

Mar
2007
Vol. 26. No. 1

Complications and Adverse Events, Introduction

Isaac M Neuhaus, MD

This issue of Seminars in Cutaneous Medicine and Surgery will focus on the various complications and adverse
events that arise in medical, surgical, and cosmetic dermatology. We are entering an exciting time for our specialty, with
numerous advances in technology and the development of new medications and products which allow us to offer unparalleled treatment options for our patients.

MORE
Jun
2012
Vol. 31. No. 2

Key Moments in the History of Dermatologic Surgery (1952-2000)

C. William Hanke, MD, MPH, FACP

The history of surgery in dermatology (“dermatologic surgery”) is rich with significant developments
and advances by multiple individuals. Only a few of these pioneers can be highlighted
in this report because of space limitations. My apologies to colleagues and friends who have
not been included or mentioned in this article. The Timeline: Major milestones in the history of
dermatologic surgery in this article tells some of the story. The biographic pieces on 15
outstanding physicians add additional detail and perspective. Many major developments have
occurred since 2000, but they are beyond the scope of this article.
Semin Cutan Med Surg 31:52-59 © 2012 Elsevier Inc. All rights reserved.

MORE
Jun
2012
Vol. 31. No. 2

The Stegman Papers: Biography of a Leader in Dermatologic Surgery

C. William Hanke, MD, MPH, FACP

The Stegman Papers is a biography of Dr. Samuel J. Stegman. The papers were collected by Dr.
Stegman during his lifetime as a dermatologic surgeon and leader. The manuscript includes a time
line of Dr. Stegman’s life and listing of his accomplishments, including significant publications.
Semin Cutan Med Surg 31:60-77 © 2012 Elsevier Inc. All rights reserved.

MORE
Mar
2007
Vol. 26. No. 1

Complications and Adverse Reactions in the Use of Newer Biologic Agents

Jeffrey P Callen, MD

New developments in genetic engineering and biotechnology have allowed the creation of bioengineered molecules that target specific steps in the pathogenesis of several immunemediated disorders, including Crohn’s disease, rheumatoid arthritis, psoriasis and psoriatic arthritis, ankylosing spondylitis, pemphigus, and B-cell lymphoma.

MORE